IPOs

IPO News – US IPO Week Ahead: Medtronic carve-out MiniMed to kick-off March activity



Two IPOs are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week.

Medtronic diabetes business carve-out MiniMed (MMED) plans to raise $742 million at a $7.4 billion market cap. Being carved out of Medtronic, MiniMed focuses on integrated diabetes management, including insulin delivery devices, continuous glucose monitors (CGMs), infusion sets, reservoirs, pen systems, and related software and services. The company’s user base exceeds 640,000 individuals on insulin pumps as of October 2025 and its CGM attachment rate reached 65% in the six months ended October 24, 2025 (versus 58% in the prior period). MiniMed commands significant market share in both pumps and CGMs, although it has seen some delays and failures in new product development.

Video streaming platform FreeCast (CAST) also plans to complete its direct listing on the Nasdaq in the week ahead. FreeCast is an entertainment-based content company that provides SmartGuide digital interactive technology for consumers to organize online media, similar to a traditional on-screen TV guide.

While not included below, Robinhood Ventures Fund I (RVI), a closed-end fund formed by Robinhood, is also set to list in the week ahead. The fund holds investments in a portfolio of private growth companies, including several notable IPO candidates.

U.S. IPO Calendar
Issuer
Business
Deal Size
Market Cap
Price Range
Shares Filed
Top
Bookrunners
FreeCast (CAST)
Orlando, FL
$158M
$356M
$8
19,782,084
 
Integrated platform for video streaming services.
MiniMed (MMED)
Northridge, CA
$742M
$7,442M
$25 – $28
28,000,000
Goldman
BofA
Carve-out of Medtronic’s diabetes management devices and technology business.

Sign up for a free trial of our premium platform, IPO Pro. To get our IPO calendar in your inbox, register here.

Street research is expected for seven companies in the week ahead, and one lock-up period will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 2/26/2026, the Renaissance IPO Index was down 0.6% year-to-date, while the S&P 500 is up 1.1%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include CoreWeave (CRWV) and Kenvue (KVUE). The Renaissance International IPO Index was up 16.4% year-to-date, while the ACWX was up 11.2%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and JX Advanced Metals.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button